Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 802 results for "alexion pharmaceuticals"

HC Stocks Reports: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), NxStage Medical, Inc. (NASDAQ:NXTM)
Share Market Updates

Alexion Pharmaceuticals, Inc. 2016 Q2 - Results - Earnings Cal...

The following slide deck was published by Alexion Pharmaceuticals, Inc. in conjunction with their 2016 Q2 earnings call. Alexion Pharmaceuticals (NASDAQ: ALXN ): Q2 EPS of $1.13 misses by $0.04. Revenue of $753.12M (+18.4% Y/Y) beats by ... Seeking Alpha, 5 hours ago
[x]  

79 images for alexion pharmaceuticals

American Banking News, 11 hours ago
Share Market Updates, 1 day ago
Jutia Group, 2 weeks ago
Octafinance, 2 weeks ago
American Banking News, 1 month ago
Nasdaq, 10 hours ago
Nasdaq, 15 hours ago
StatNews.com, 2 weeks ago
Nasdaq, 2 weeks ago
Share Market Updates, 3 weeks ago

Alexion Pharmaceuticals revenues up 18% in Q2; updates guidance

Alexion Pharmaceuticals ( ALXN +2.3%) Q2 results : Revenues: $753.1M (+18.4%); Operating Income: $194.7M (+7.5%); Net Income: $114.9M (-32.5%); EPS: $0.51 (-38.6%); Non-GAAP EPS: $1.13 (-13.1%); Quick Assets: $1,180.1M (-14.8%). 2016 Guidance : ...
 Seeking Alpha11 hours ago

BRIEF-Alexion reports Q2 non-gaap EPS $1.13

July 28 Alexion Pharmaceuticals Inc : * Sees FY non gaap earnings per share $4.50 to $4.65 * Sees FY non gaap total revenues $3,050 to $3,100 million * FY2016 earnings per share view $5.05, revenue view $3.06 billion -- Thomson Reuters ...
 Reuters UK15 hours ago

Alexion Pharmaceuticals misses by $0.04, beats on revenue

s Editor Alexion Pharmaceuticals (NASDAQ:ALXN): Q2 EPS of $1.13 misses by $0.04. Revenue of $753.12M (+18.4% Y/Y) beats
 Seeking Alpha16 hours ago
Nasdaq

Alexion (ALXN) Tops Q2 Earnings and Revenues (Revised)

Alexion Pharmaceuticals, Inc. 's ALXN second-quarter 2016 earnings (including stock-based compensation expense) of 93 cents per share surpassed the Zacks Consensus Estimate of 91 cents. Earnings were, however, lower than the year-ago figure of ...
 Yahoo! Singapore10 hours ago
[x]  

Alexion Pharma Q2 Profit Declines, Cuts FY16 Adj. EPS Outlook

(RTTNews) - Alexion Pharmaceuticals Inc. (ALXN) Thursday announced a decline in second quarter net income to $114.94 million on higher operating and income tax expenses from $170.22 million in the prior year. Earnings per share declined to $0.51 ...
 Quotenet.com15 hours ago
Nasdaq

Alexion (ALXN) Beats on Q2 Earnings and Revenues

Alexion Pharmaceuticals, Inc. ALXN focuses on the development and commercialization of life-transforming drugs for treating patients suffering from ultra-rare disorders. Soliris approved for paroxysmal nocturnal hemoglobinuria and atypical hemolytic ...
 Yahoo! Singapore13 hours ago
[x]  
Nasdaq

Alexion misses 2Q profit forecasts

NEW HAVEN Alexion Pharmaceuticals Inc. reported second-quarter profit of $114.9 million and cut its expectations for net income this year. The New Haven, Connecticut, company posted a profit of 51 cents per share. Earnings, adjusted for ...
 NewsFlow2413 hours ago Alexion Pharmaceuticals Inc. Q2 Earnings Retreat 4%  Nasdaq15 hours ago
Real Estate Weekly

ALEXION PHARMACEUTICALS : Cuts Profit Guidance

By Austen Hufford Alexion Pharmaceuticals Inc. reported that revenue increased but profit fell as the rare drug market continues to ramp up sales of new drugs. The company, which focuses on a narrow range of treatments for rare diseases, also cut ...
 4 Traders15 hours ago Alexion Pharmaceuticals Cuts Profit Guidance  ADVFN India14 hours ago Blackstone affiliate trades $1.5B life sciences portfolio  Real Estate Weekly2 weeks ago Will Ventas Gain from $1.5B Life-Sciences Real Estate Deal?  Zacks.com3 weeks ago
[x]  
BioSpace

Five new member companies, Alexion, Jazz, Teva, AMAG and Horizon join with PhRMA

The Pharmaceutical Research and Manufacturers of America (PhRMA) announced three biopharmaceutical research companies joined the association as members and two transitioned from research associates to full members. The new members are Alexion ...
 PharmaBiz1 week ago With new additions, PhRMA opens door to generics drugmaker Teva  BioPharma Dive1 week ago PhRMA adds five new member companies  Center Watch1 week ago PhRMA Welcomes Five New Member Companies  4 Traders1 week ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - alexion pharmaceuticals
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less